PERMETHRIN


Trade Names	ELIMITE NIX PERMETHRIN
Synonyms	Activyl tick plus Elimite Lyclear Lythrin NSC-760105 Permethrin
Status
Molecule Category	UNKNOWN
ATC	P03AC04
UNII	509F88P9SZ
EPA CompTox	DTXSID8022292


Active Pharmaceutical Ingredients Bioactive chemicals	Exact Similarity SubStructure	Threshold (%) >= 70

Structure


InChI Key	RLLPVAHGXHCWKJ-UHFFFAOYSA-N
Smiles	CC1(C)C(C=C(Cl)Cl)C1C(=O)OCc1cccc(Oc2ccccc2)c1
InChI	InChI=1S/C21H20Cl2O3/c1-21(2)17(12-18(22)23)19(21)20(24)25-13-14-7-6-10-16(11-14)26-15-8-4-3-5-9-15/h3-12,17,19H,13H2,1-2H3

Physicochemical Descriptors

Property Name	Value
Molecular Formula	C21H20Cl2O3
Molecular Weight	391.29
AlogP	6.11
Hydrogen Bond Acceptor	3.0
Hydrogen Bond Donor	0.0
Number of Rotational Bond	6.0
Polar Surface Area	35.53
Molecular species	NEUTRAL
Aromatic Rings	2.0
Heavy Atoms	26.0

Bioactivity

Mechanism of Action	Action	Reference
Voltage-sensitive sodium channel blocker	BLOCKER	DailyMed Wikipedia Wikipedia Wikipedia

Assay Description	Organism	Bioactivity	Reference
Insecticidal activity against first-instar larvae of Cheumatopsyche brevilineata after 48 hr	Cheumatopsyche	0.000205 ug.mL-1
Insecticidal activity against Daphnia magna after 48 hr	Daphnia magna	0.0006 ug.mL-1

Related Entries

Cross References

Resources	Reference
ChEBI	34911
ChEMBL	CHEMBL1525
DrugBank	DB04930
DrugCentral	4152
FDA SRS	509F88P9SZ
Human Metabolome Database	HMDB0015604
PharmGKB	PA164743137
PubChem	40326
SureChEMBL	SCHEMBL26543

CONTENTS


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).